11.07.14
San Jose, Calif.-based SI-Bone Inc., provider of the iFuse implant system, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, will host a symposium during the North American Spine Society (NASS) annual meeting. The symposium, held on Nov. 12, will feature a panel of speakers who will cover a broad range of topics on the diagnosis and treatment of SI joint disorders.
Scott Kitchel, M.D., of the Neurospine Institute in Eugene, Ore., will present the underlying anatomic and biomechanical rationale for why the SI joint can be a source of lower back pain. Joseph Fortin, D.O., from the Spine Technology and Rehabilitation Center in Fort Wayne, Ind., will discuss his approach on how to properly diagnose the SI joint as a source of low back pain. Peter Whang, M.D., from the Yale University School of Medicine in New Haven, Conn., will present the existing published clinical evidence supporting MIS SI joint fusion surgery using the iFuse implant system including the recently published five year results.
“The annual NASS meeting brings together spine care professionals from all around the world and provides a great venue to discuss the role of the SI joint as a source of low back pain,” said Jeffrey Dunn, president and CEO of SI-Bone. “The SI joint is now seen by many as the most underserved area of the spine and one that is positioned for significant growth now that there is substantial published clinical evidence. The data is also showing that there are a large number of patients suffering from low back pain who are under-diagnosed or misdiagnosed.”
SI-Bone received original 510(k) clearance in November 2008 from the U.S. Food and Drug Administration to market its iFuse implant system. The CE mark for European commercialization was obtained in November 2010.
The SI joint symposium will be held on Nov. 13th, from 5:30 to 7:30 pm at the W Hotel. The event is open to all healthcare professionals attending NASS who have an interest in learning more about the diagnosis and treatment of patients suffering from certain causes of SI joint low back pain.
Scott Kitchel, M.D., of the Neurospine Institute in Eugene, Ore., will present the underlying anatomic and biomechanical rationale for why the SI joint can be a source of lower back pain. Joseph Fortin, D.O., from the Spine Technology and Rehabilitation Center in Fort Wayne, Ind., will discuss his approach on how to properly diagnose the SI joint as a source of low back pain. Peter Whang, M.D., from the Yale University School of Medicine in New Haven, Conn., will present the existing published clinical evidence supporting MIS SI joint fusion surgery using the iFuse implant system including the recently published five year results.
“The annual NASS meeting brings together spine care professionals from all around the world and provides a great venue to discuss the role of the SI joint as a source of low back pain,” said Jeffrey Dunn, president and CEO of SI-Bone. “The SI joint is now seen by many as the most underserved area of the spine and one that is positioned for significant growth now that there is substantial published clinical evidence. The data is also showing that there are a large number of patients suffering from low back pain who are under-diagnosed or misdiagnosed.”
SI-Bone received original 510(k) clearance in November 2008 from the U.S. Food and Drug Administration to market its iFuse implant system. The CE mark for European commercialization was obtained in November 2010.
The SI joint symposium will be held on Nov. 13th, from 5:30 to 7:30 pm at the W Hotel. The event is open to all healthcare professionals attending NASS who have an interest in learning more about the diagnosis and treatment of patients suffering from certain causes of SI joint low back pain.